Paper17577015
Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.
Bartelink H and 11 others. J Clin Oncol, 2007. Cited by 718 papers, by iCite.
Cite this record
ConductScience Library. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. Papers, record 17577015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17577015
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.
- PubMed
- Publication types
- Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Dose Fractionation, Radiation | Major topic |
| Adult | |
| Combined Modality Therapy | |
| Disease Progression | |
| Disease-Free Survival | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Mastectomy, Segmental | |
| Middle Aged | |
| Neoplasm Recurrence, Local | |
| Radiotherapy Dosage | |
| Risk Factors | |
| Treatment Outcome |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 2U10-CA11488-36 | NCI NIH HHS | United States | U10CA114883 | PubMed | NIH RePORTER |
| 5R10-CA11488-11 | NCI NIH HHS | United States | R10CA114881 | PubMed | NIH RePORTER |
| R10CA011488 | NIH | NIH RePORTER | |||
| U10CA011488 | NIH | NIH RePORTER |
Trials8
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00907868 | Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ (BONBIS) | Background | ClinicalTrials.gov | |
| NCT02114086 | IORT-Boost-Study, Prospective Observational Study for Intraoperative Radiotherapy of the Breast as a Boost | Background | ClinicalTrials.gov | |
| NCT02858934 | Feasibility Study of Accelerated Preoperative Radiotherapy for Early Breast Cancer | Background | ClinicalTrials.gov | |
| NCT02913729 | Pre- Versus Postoperative Accelerated Partial Breast Irradiation | Background | ClinicalTrials.gov | |
| NCT03077191 | Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience | Background | ClinicalTrials.gov | |
| NCT04414202 | Observational Study of Intra-operative Partial Irradiation of Invasive Ductal Breast Carcinomas With a Good Prognosis | Background | ClinicalTrials.gov | |
| NCT06946238 | Single-fraction APBI for Early-stage Breast Cancer With Favorable Histological Subtypes (Breast-1F) | Results | ClinicalTrials.gov | |
| NCT07020780 | 5 fr Ultrahypofractionated WBI and SIB for Breast Cancer With Unfavorable Characteristics | Results | ClinicalTrials.gov |
Comments and corrections6
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 18089888 | Enhanced local control by radiation boost in breast cancer: back side of the coin? | https://conductscience.org/library/papers/18089888 | PubMed |
| Comment in | 18089889 | What is the impact of tamoxifen on radiation-induced fibrosis in patients receiving breast-conserving therapy. | https://conductscience.org/library/papers/18089889 | PubMed |
| Comment in | 18089890 | Boost dose back again in elderly. | https://conductscience.org/library/papers/18089890 | PubMed |
| Comment in | 18281678 | Boost or not. | https://conductscience.org/library/papers/18281678 | PubMed |
| Comment in | 18640495 | Radiation-induced side effects with or without systemic therapies: prime time for prediction of individual radiosensitivity. | https://conductscience.org/library/papers/18640495 | PubMed |
| Comment in | 21263085 | More questions about the European Organisation for Research and Treatment of Cancer 22881-10882 boost trial. | https://conductscience.org/library/papers/21263085 | PubMed |
Cited by262
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 718 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42783504 | The Tumor-Bed Boost Irradiation in Early-Stage Breast Cancer 30 Years After the Landmark Trials: What Is New? | J Pers Med | 2026 | https://conductscience.org/library/papers/42783504 | PubMed |
| 42604117 | Transitioning from neoadjuvant chemoradiation to perioperative chemotherapy for esophageal adenocarcinoma: Impact on margins and pathologic outcomes. | JTCVS Open | 2026 | https://conductscience.org/library/papers/42604117 | PubMed |
| 42312740 | Evaluation of 3D-CRT vs. VMAT for radiotherapy of whole breast with simultaneous integrated boost. | Acta Oncol | 2026 | https://conductscience.org/library/papers/42312740 | PubMed |
| 42049401 | Helical Tomotherapy in Local Advanced Breast Cancer Following Mastectomy: Long-term Results and Late Toxicity Analysis. | In Vivo | 2026 | https://conductscience.org/library/papers/42049401 | PubMed |
| 41987326 | Dosimetric comparison of sequential planning (SP) versus bias dose planning (BDP) in volumetric modulated arc therapy (VMAT)-based breast radiotherapy boost. | J Appl Clin Med Phys | 2026 | https://conductscience.org/library/papers/41987326 | PubMed |
| 41510712 | Breast Cancer: Challenges in the Treatment and Prodrug Strategies. | Mini Rev Med Chem | 2026 | https://conductscience.org/library/papers/41510712 | PubMed |
| 41491223 | Distant recurrence and margin involvement in invasive breast cancer. | Br J Cancer | 2026 | https://conductscience.org/library/papers/41491223 | PubMed |
| 41485765 | Reoperation Versus Dose-Escalated Radiotherapy for Ductal Carcinoma In Situ at the Surgical Margin After Breast-Conserving Surgery for Invasive Ductal Carcinoma. | J Breast Cancer | 2025 | https://conductscience.org/library/papers/41485765 | PubMed |
| 41007715 | A Biological-Driven Approach to Explore Dose-Escalated Ultra-Hypofractionation in Breast Cancer Radiotherapy. | Biomedicines | 2025 | https://conductscience.org/library/papers/41007715 | PubMed |
| 40914778 | Preoperative Radiation Boost in Early-Stage Breast Cancer: Effect on Re-excision and Complication Rates. | Ann Surg Oncol | 2025 | https://conductscience.org/library/papers/40914778 | PubMed |
| 40837646 | Clinical comparison of simultaneous integrated and sequential boost IMRT of tumor bed after breast conserving surgery. | Afr Health Sci | 2025 | https://conductscience.org/library/papers/40837646 | PubMed |
| 40836156 | Preoperative Radiation Boost Results in Low Rates of Re-excision and Reduced Locoregional Treatment Time in Breast Cancer Patients. | Ann Surg Oncol | 2025 | https://conductscience.org/library/papers/40836156 | PubMed |
| 40708010 | Optimizing intraoperative radiotherapy as a tumor bed boost with whole-breast irradiation in breast cancer. | World J Surg Oncol | 2025 | https://conductscience.org/library/papers/40708010 | PubMed |
| 40699594 | Long-Term Locoregional Outcomes in a Contemporary Cohort of Young Women With Breast Cancer. | JAMA Surg | 2025 | https://conductscience.org/library/papers/40699594 | PubMed |
| 40575221 | Radiation Recall Phenomenon Following Vaccination in a Patient With Prior Radiation to Lower Extremity Liposarcoma. | Cureus | 2025 | https://conductscience.org/library/papers/40575221 | PubMed |
| 40469948 | Comparison of simultaneous integrated tumor bed boost and sequential boost during hypofractionated whole-breast irradiation after breast-conserving surgery. | Clin Transl Radiat Oncol | 2025 | https://conductscience.org/library/papers/40469948 | PubMed |
| 40387868 | Oncological outcomes of breast cancer patients after planned IORT boost with low-kV x-rays-results of the TARGIT BQR prospective phase IV trial. | Strahlenther Onkol | 2026 | https://conductscience.org/library/papers/40387868 | PubMed |
| 40337265 | Whole-breast irradiation with lumpectomy cavity boost and regional nodal irradiation: Dosimetric comparison of 3D-CRT using sequential boost and dual partial-arc VMAT using simultaneous integrated boost. | Precis Radiat Oncol | 2023 | https://conductscience.org/library/papers/40337265 | PubMed |
| 40281617 | Effect of re-excision on local recurrence in patients with involved or close margins after upfront breast-conserving surgery: a systematic review and meta-analysis. | World J Surg Oncol | 2025 | https://conductscience.org/library/papers/40281617 | PubMed |
| 40029831 | Understanding the early molecular changes associated with radiation therapy-A preliminary bulk RNA sequencing study. | PLoS One | 2025 | https://conductscience.org/library/papers/40029831 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17577015
GET https://conductscience.org/api/papers/v1/17577015/cited_by?page=2